COVID-19: Gilead ties up with Cipla, Mylan, Jubilant and two others to produce, sell Remdesivir in 127 countries

Indian companies Mumbai-headquartered Cipla, Hyderabad-based Hetero Labs and Noida-based Jubilant Life Sciences has signed up the agreement to manufacture the drug and to sell it in 127 countries.